GAITHERSBURG, Md., July 12, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) announced today that the New York State Department of Health (NYSDOH) has approved the Acuitas® MDRO Gene Test for use by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback